Summary: Hemoglobin and its metabolite, bilirubin, have been shown to be present in high concentrations in CSF following subarachnoid hemorrhage (SAH) . Several re ports have indicated that hemoglobin is a potent cerebral vasoconstrictor and therefore is considered to be an ac tive principle in the genesis of cerebral vasospasm. The possible role of bilirubin on the genesis of cerebral vaso spasm, however, has not been clarified. The effect of bilirubin on cerebral vessel tone was therefore examined using in vitro tissue bath techniques. Bilirubin 00 -5-3 x 10 -5 M) induced strong constriction of cerebral arteries from the cat, dog, and pig. The vasoconstriction returned to baseline after bilirubin was washed by prewarmed Krebs solution. Vasomotor responses to various vasoac tive substances were then examined after bilirubin was washed away (the bilirubin postwash effect). Norepi nephrine (NE)-induced but not serotonin-or acetylcho line (ACh)-induced constrictions were significantly po tentiated by bilirubin postwash effect. The potentiated NE-induced constriction was attenuated by yohimbine but not by prazosin. This enhanced vasoconstriction was Cerebral vasospasms have been reported to oc cur frequently in patients following subarachnoid hemorrhage (SAH). The acute vasospasm may oc cur within 4-24 h (Brawley et aI., 1968) , while the delayed vasospasm develops from 2 to 14 days (Stomell and French, 1964) , sometimes up to 4 weeks after bleeding (Svendgaard et aI., 1977b) . The acute vasospasm is probably due to direct stim ulation of vascular muscle cells by circulating vaso-mimicked by clonidine but not by phenylephrine, suggest ing that the potentiation of NE-induced constriction by the bilirubin postwash effect was mediated by the u2-adrenoceptor subtype. The bilirubin postwash effect also resulted in blockade of endothelium-dependent va sodilations induced by A-23147, ACh, and ATP without affecting relaxations induced by direct muscle relaxants such as l3-adrenoceptors, papaverine, and sodium nitro prusside. These results indicate that bilirubin induces di rect vasoconstriction, potentiates u2-adrenoceptor mediated vasoconstriction, and inhibits endothelium dependent vasodilation. These actions of bilirubin may promote an enhanced overall vasoconstriction in vivo. Bilirubin, therefore, may be involved in the genesis of cerebral vasospasm following SAH. Key Words: u2-Adrenoceptor-mediated vasoconstrictions-Bili rubin-Bilirubin postwash effects-Cerebral vessel tone-Endothelium-independent vasodilations Endothelium-mediated vasodilations-Subarachnoid hemorrhage-induced vasospasm.
active substances such as serotonin (5-HT) and prostaglandin F2a (Brawley et aI., 1968; Chow et aI., 1968; Smith et aI., 1973) . The etiology of the delayed vasospasm, which is clinically more seri ous, is less understood.
It has been reported that injection of whole blood (Echlin, 1965) or 7-day aged blood (Miyaoka et aI., 1976) into the subarachnoid space results in vaso spasm of pial arteries. Hemolysates (membrane free erythrocyte extracts) (Cheung et aI., 1980; Lee et aI., 1984) and hemoglobin (Boullin et aI., 1983; Lee et aI. , 1988) have been shown to induce potent cerebral vasoconstriction. In addition, hemoglobin and hemolysates have been shown to block neuro genic vasodilation, potentiate neurogenic vasocon striction (Lee et aI., 1984) , and inhibit endothelium mediated relaxations ( N akagomi et aI., 1987; Lee et aI., 1988) . Hemoglobin, therefore, has been pro posed to be an active principle in the genesis of the SAH-induced vasospasm.
Bilirubin, the metabolite of hemoglobin, has also been found in significant concentrations, which can be as high as 10-4 M, in CSF of patients following SAH (Froman and Smith, 1967; Marlet and Barretto Fonseca, 1982) . The peak level of hemoglobin is reached around day 2 (Barrows et aI. , 1955; Marlet and Barretto Fonseca, 1982) and that of bilirubin is seen approximately at day 8 (Marlet and Barretto Fonseca, 1982) following SAH. This rise in bilirubin level paralleled the time course of post -SAH vaso spasm (Marshal, 1973) . The vasomotor effect of bil irubin and its potential involvement in the genesis of cerebral vasospasm have not been fully investi gated. The present study therefore was designed to examine the effects of bilirubin of reactivities of isolated cerebral arteries. The result indicates that bilirubin enhances overall contractile responses of cerebral arteries, suggesting that it may be involved in the pathogenesis of cerebral vasospasm.
MATERIALS AND METHODS
Adult animals including 38 cats (2-4 kg), 6 dogs (40-60 kg), and 8 pigs (60-70 kg) of either sex were used in this experiment. Cats and dogs were anesthetized by intraper itoneal or intravenous administration of sodium pentobar bital (Nembutal, 40 mg/kg), respectively, and exsangui nated. Fresh pig heads were obtained from a local slaugh terhouse. Entire brains, with pial arteries attached, were carefully removed and placed in Krebs bicarbonate solu tion equilibrated with 95% of O2 and 5% CO2 at room temperature. The composition of the Krebs solution was as follows (mM): NaCI, 96.87; KCI, 5. 16; MgS0 4 , 1.22; NaHC03, 25.56; CaCI2, 1.33 ; I-ascorbic acid, 0.11; ethyl enediaminetetraacetic acid, 0.34; and dextrose, 1. 01. Ce rebral blood vessels were dissected and cleaned of sur rounding tissue under a dissecting microscope. The cra nial portion of internal carotid arteries (anterior part of circle of Willis) of the cat and pig and basilar arteries of the dog were used in this experiment. Ring segments (2-3 mm long) of the arteries were carefully cannulated with a stainless-steel rod (30-gauge) of hemispherical section and a short piece of platinum wire, then mounted in an isolated tissue bath containing 18 or 25 ml Krebs solution. The tissue baths were designed as an overflow system to allow the prewarmed fresh Krebs solution to enter from the bottom of the chamber. The platinum wire was bent into an inverted U shape and anchored to a plastic gate, which was adjusted using a fine control micrometer (Unislide series AI500). Changes of the vascular isomet ric force were measured using a UC-3 force-displacement transducer. After 10 min the temperature of the Krebs solution was gradually increased to and maintained at 37°C. Resting tension was then set at 0. 5, 0. 75, and 1 g for cat, pig, and dog cerebral arteries, respectively. A period of 1 h was allowed for equilibration.
Dose-response relationships
Dose-response relationships for vasodilation and vaso constriction in response to different vasoactive sub stances were obtained by a cumulative method. The doses that produced 50% of the maximum relaxation or contraction (EDso values) were determined for each arte rial ring. From these values, the geometric means for EDso with 95% confidence intervals were calculated (Fleming et aI. , 1972) .
To examine the effects of bilirubin on drug-induced re sponses, two consecutive dose-response curves were ob tained from each tissue. The second dose-response curve was obtained 15 min after the addition of bilirubin or 15 min after bilirubin was washed away with fresh Krebs solution. That is, the effects of bilirubin on drug-induced responses were examined in the presence or in the ab sence (postwash) of bilirubin.
To examine the endothelium-dependent vasodilator re sponses, the extrinsic active muscle tone of -500 mg was induced by UTP in arteries with intact endothelial cells.
At the end of each experiment, a dose of papaverine (PPV) (3 x 10-4 M) was given to maximally relax the arteries (Lee et aI. , 1984) .
Preparation of bilirubin solution
A saturated solution of bilirubin was prepared by dis solving 0. 5847 g in 1, 000 ml deionized water; it was fil tered and stored in the dark. The concentration of biliru bin was determined spectrophotometrically using biliru bin standard solutions and reactants from Sigma (Walters and Gerarde, 1970) . The concentration of the stock solu tion was -10-4 M.
Statistical methods and drugs
Results were computed as mean values ± SEM and the significant differences between the two dose-response curves were determined by two-way analysis of variance (ANOV A) and the Newman-Keul test. The significant differences between maximum responses and those be tween EDso values were determined by paired Student t tests. Probabilities of <0. 05 were considered to be statis tically significant.
The sources of chemicals used in the present experi ment were as follows: sodium pentobarbital (Nembutal; Abbott Lab, Chicago, IL, U. S.A.); UTP sodium salt, 1norepinephrine (NE), acetylcholine chloride (ACh) , 5hydroxytryptamine-creatinine sulfate complex [serotonin (5-HT)], I-isoproterenol bitartrate (ISO), dl-propranolol hydrochloride, yohimbine hydrochloride, sodium nitro prusside (SNP), carbamylcholine chloride [carbachol (CCh)], ATP sodium, 8-phenyltheophylline, imipramine hydrochloride, papaverine hydrochloride, and bilirubin (Sigma, St. Louis, MO, U. S. A. ); prazosin hydrochloride (Pfizer Inc., Groton, CT, U. S. A.); phentolamine hydro chloride (Regitine; CIBA Pharmaceutical Co. , Tuckahoe, NY, U. S.A. ); and A-23187 (Calbiochem, Branch of Behring Diagnostics, La Jolla, CA, U. S.A.).
RESULTS

Vasoconstrictions induced by bilirubin
In 78 of 80 preparations, bilirubin (10-7 -3 x 10 -5 M) induced dose-dependent contractions of cere bral arteries from several species investigated ( Fig.  lA, B , and D). The bilirubin-induced vasoconstric tions were not significantly affected by removal of the endothelial cells (Fig. 10 ). The maximum con tractions induced by bilirubin were greater than those induced by NE, 5-HT, and ACh ( Fig. lA  and B ).
Effects of bilirubin on vasoconstriction induced by NE
Consistent with previous findings in several spe cies (Duckles and Bevan, 1976; Lee et al., 1981) , the NE contractile dose-response curves in cerebral arteries of the dog and cat were composed of two phases: an initial phase of smaller contractions in duced by NE in concentrations from 10 -6 to 3 X 10-4 M, followed by a second phase of sharply el evated contractile responses induced by higher con centrations ofNE 00-3 -3 x 10-3 M) ( Fig. lC ; Ta ble 1). Since the sharply elevated contractile re- Vol. 9, No.5, 1989 sponses may be mediated by non-u-adrenergic receptors (Edvinsson and Owman, 1974; Bevan, 1981) , the effect of bilirubin on the initial phase of NE dose-response curves was examined. In the presence of bilirubin (3 x 10-5 M), NE-induced contractions were usually similar to or smaller than the contractions induced before addition of bilirubin (Fig. 2) . However, after bilirubin was washed away and the vessel tone returned to the original baseline, NE-induced contractile responses were signifi cantly potentiated (Figs. 2 and 3A) . This bilirubin postwash effect significantly shifted the NE dose response curves to the left (Fig. 3A) with an en hanced maximum contraction (248.4 ± 25.4% in crease; p < 0.01) but did not significantly affect the EDso values (4.1 x 10-6 M vS. 2.3 X 10-6 M; p < 0.05, n = 17) ( Table 2) . Similar results were ob tained with clonidine (a selective u2-adrenoceptor agonist) but not with phenylephrine (a selective ul-adrenoceptor agonist) ( Table 2 ). In fact, the phenylephrine-induced vasoconstrictions were in hibited in bilirubin postwash preparations.
Effects of <X1-and <x2-receptor antagonists
The potentiated NE-induced vasoconstrictions by the bilirubin postwash effect were significantly attenuated upon application of yohimbine, an u2-adrenoceptor antagonist (Fig. 3A) . On the other hand, prazosin, an u1-adrenoceptor antagonist, only at very high concentrations, slightly attenuated the NE-induced contractions (Fig. 3B ).
Effects of bilirubin on vasoconstriction induced by 5-HT and ACh 5-HT induced contractions of cerebral arteries with or without endothelial cells. ACh induced con tractions of arteries without endothelial cells. The contractions induced by both agonists were not af fected by the bilirubin postwash effects (Table 2 ). There were no significant differences between ei ther maximum contractions or EDso values in con trol and bilirubin postwash groups for either agonist (p > 0.05) ( Table 2) .
Effects of bilirubin on endothelium-dependent vasodilations
In the presence of UTP-induced active muscle tone, ACh, CCh, A-23187, and ATP produced dose dependent relaxations in cerebral arteries with in tact endothelial cells (Figs. 4 and 5) . The maximum responses to ACh, CCh, A-23187, and ATP in con trol groups were 48.68 ± 5.84% (n = 14), 57.26 ± 16.22% (n = 5), 82.88 ± 21.22% (n = 4), and 92.13 ± 10.24% (n = 8) of PPV (3 x 10-4 M)-induced maximum relaxation, respectively. The relaxations induced by these vasodilators were significantly blocked in the presence of bilirubin and after biliru bin was washed away (bilirubin postwash effect) (p > 0.01) (Figs. 4 and 5; Table 3 ).
Effects of bilirubin on endothelium-independent vasodilations
Vasodilations induced by IS O, NE, PPV, and SN P in the pig and cat internal carotid arteries were independent of endothelial cells (Lee et aI., 1982) . The maximum responses to ISO, NE, PPV, and SN P were 60.17 ± 14.4% (n = 5), 102.89 ± 16.11% (n = 6), 98.33 ± 1.67% (n = 6), and 111.72 ± 6.71% (n = 4) of PPV-induced maximum relaxation, re spectively. The vasodilations induced by these ag onists were not significantly affected by the biliru bin postwash effect (Table 3 ). There were no signif- icant differences in maximum relaxation between control and bilirubin postwash preparations for all agonists (p < 0.01) ( Table 3) .
DISCUSSION
The present study demonstrated that bilirubin, a metabolite of hemoglobin, induced strong vasocon striction of cerebral arteries. Preexposure of cere bral arteries to bilirubin resulted in a potentiation of the (X2-adrenoceptor-mediated vasoconstriction and an attenuation of endothelium-mediated vasodila tion. Bilirubin pretreatment, however, did not af fect the contractions induced by 5-HT and ACh or the relaxations induced by direct vasodilator drugs such as [3-adrenoceptor agonists, SN P, and PPV. It has been reported that in patients following SAH, up to 1.6 X 10 9 erythrocytes/ml were found in the CSF, i.e., 44 ml of blood in 150 ml CSF (Boullin et aI., 1983) . In fact, the concentration of hemoglo bin in CSF from SAH patients has been reported to be as high as 4.19 x 10-4 M (Froman and Smith, 1967) . Since 1 molecule of hemoglobin yields 1 mol ecule of bilirubin, a high concentration of bilirubin in CSF would be expected. This concentration of bilirubin is -10 times higher than that used to in duce maximum vasoconstriction and to exhibit the bilirubin postwash effects in the present study.
The mechanism by which bilirubin induces direct constriction of cerebral blood vessels remains un known. It is unlikely due to the activation of adren ergic, cholinergic, or serotonergic receptors since the appropriate receptor antagonists did not affect bilirubin-induced contractile responses (unpub lished observations). The vasoconstriction induced by bilirubin was not endothelium dependent since removal of endothelial cells failed to affect the bil- Two consecutive dose-response curves to NE before application of Bb were used as control. There was no significant difference between the two control dose-response curves (p > 0.05). Bb significantly shifted the curve to the left of con trol with an increased maximum contraction (p irubin-induced vasoconstriction. The contractile ef fect of bilirubin on cerebral arteries appears to be unique since bilirubin induced a relatively weak constriction of the peripheral arteries examined (un published observations).
It has been shown that vasoconstrictor responses to NE are significantly increased in post-SAH ce rebral blood vessels (Svendgaard et aI., 1977 a; Lo bato et aI., 1980) . Morphological studies further demonstrated that adrenergic nerves in cerebral blood vessels degenerated following SAH (Symon, 1971; Svendgaard et aI., 1977b; Endo and Suzuk, 1979; Edvinsson et aI., 1982) . This was accompa nied by greatly diminished NE content, decreased eH] NE uptake, and considerably reduced activity of dopamine-�-hydroxylase in cerebral arteries 3-7 days after SAH (Svendgaard et aI., 1977b) . Thus, denervation supersensitivity may account in part for the enhanced responses to catecholamines. Fur thermore, blockade of the post-SAH potentiated ex-adrenoceptor-mediated constriction by phentol- CCh _lj l 1 l 5 0 5 ! t 6 . 5 UTP 7 7 . 5 amine (Svendgaard et aI., 1977 b; Lobato et aI., 1980) and other a-adrenoceptor antagonists (Cum mins and Griffith, 1971; Smigiel and Sundt, 1974) suggests that a-adrenoceptors may play a role in the genesis of the delayed vasospasm. This suggestion of a potential role of denervation supersensitivity in brain arteries following SAH, however, is not sup ported universally. Contractile responses to NE were either unchanged or decreased in magnitude in some SAH animal models, leading to the suggestion that post-SAH responses of cerebral arteries to NE may be diminished (Duff et aI., 1987) .
In the present study with an isolated arterial prep aration, both decreases and increases in contractile responses to NE after pretreatment with bilirubin were demonstrated. In the presence of bilirubin, NE induced similar or smaller contractions com pared with those in control preparations. On the other hand, once bilirubin was washed away, the contractile responses to NE were significantly en hanced (the bilirubin postwash effect). Thus, biliru bin, depending on concentration, can decrease or enhance NE-induced vasoconstrictor responses. The controversy over findings of either potentiation or attenuation of contractile responses to NE in cerebral arteries from chronic SAH animals 4 . 5 Results from studies on most peripheral arteries suggest that NE neurotransmitters stimulate postsynaptic a,-adrenoceptors and that NE acti vates postsynaptic a2-adrenoceptors to induce va soconstrictions (Langer and Shepperson, 1982) . In cerebral arteries, the postsynaptic a-adrenergic re ceptors mediating contractile responses have been shown to be primarily of the a2-subtype (Sakakibara et aI., 1981; Skarby et aI., 1981; Medgett and Langer, 1983; Tsukahara et aI., 1983) . Maximum binding of NE to a2-adrenoceptors is increased in cerebral blood vessels from SAH victims (Tsuka hara et aI., 1985) . This latter observation is consis tent with our present findings in the bilirubin post wash preparations that the cerebral vasoconstrictor responses to NE and clonidine were greatly en hanced. Tsukahara et ai. (1985) , however, reported a decreased a2-adrenoceptor affinity in cerebral blood vessels obtained from SAH victims. This is different from the present finding that the ED 5 0 val ues for NE-induced constriction of cerebral arteries were not affected by bilirubin. Following exposure to Bb, which was then washed away (postwash), the vasodilator responses to ACh and CCh were significantly attenuated (p < 0.01). In the presence of active muscle tone induced by UTP, both A-23187 and ATP also produced dose-dependent relaxations before exposure to Bb. In the presence of Bb or even after Bb was washed away (postwash), the dilator responses to ATP and A-23187 were significantly attenuated (p < 0.01). Data are expressed as percentage of the maximum relaxation induced by 3 x 10-4 M papaverine (PPV). Vertical bars represent SEMs. n, no. of specimens examined.
The determination of the exact affinity using a receptor-binding approach, however, is not ideal since adrenergic radioligands may also bind to non-a-adrenoceptors or -y-adrenoceptors (Angus, 1982) . In rabbit basilar arteries, NE dose-response curves were shown to exhibit two components: an initial component of gradual increase in contraction reaching a plateau at 3 x 10-4 M NE, followed by a sharply elevated response at higher NE concen trations up to 3 X 10-3 M, which produced maxi-J Cereb Blood Flow Metab, Vol. 9, No.5, 1989 mum contraction (Lee et aI., 1981) . The receptors responsible for the first component were a-adrenoceptors and those for the sharply elevated contractile responses were suggested to be non a-adrenoceptors, which could be ""I adreno ceptors" (Bevan, 1981) . The contractile responses of the first component (present result) and second component (our preliminary result) were potenti ated by the bilirubin postwash effect, suggesting that non-a-adrenoceptor-mediated constrictions were also affected by bilirubin. These finds indicate that interpretation of the receptor binding study should be made carefully. The purpose of using NE doses below 3 x 10 -4 M in the present study, there fore, was to rule out the possible influence of the non-a-adrenoceptors.
The contractions potentiated by the bilirubin postwash effect were blocked by a2-but not aI-adrenergic receptor antagonists. These effects were mimicked by selective a2-adrenoceptor ago nists but not by selective al-adrenoceptor agonists. In these preparations, similar results were obtained when (3-adrenoceptors and/or neuronal uptake was also blocked. These results suggest that a2-but not al-adrenoceptor-mediated cerebral vasoconstric tions are potentiated by the bilirubin postwash ef fect. The specificity in potentiation of the a2-adrenoceptor-mediated constriction was further supported by the finding that al-adrenoceptor-, ACh-, and 5HT-induced constrictions were not po tentiated by the bilirubin postwash effect.
It should be pointed out that pig cerebral arteries have been shown to contain predominantly (3-adrenoceptors (Lee et aI., 1982) and therefore are ideal preparations for studying the effects of biliru bin on (3-adrenoceptor-mediated dilation. In the bil irubin postwash preparations, ISO-or NE-induced cerebral vasodilations were not different from those of the control. Similar results were obtained in preparations pretreated with phentolamine before treatment with ISO or NE. In parallel studies, PPV induced relaxations were not affected by the biliru bin postwash effect. These results suggest that the acute application of bilirubin does not affect the vascular responses to direct vasodilators such as (3-adrenergic agonists and PPV, which are known to increase cyclic AMP levels (Gilman, 1984; Suna gane et aI., 1984) . SN P, an endothelium-independent vasodilator, has been reported to increase cyclic GMP levels in smooth muscle cells (Rapoport and Murad, 1983) through activation of guanylate cyclase (Katsuki et aI., 1977) . Results from the present study indicate that SN P-induced vasodilations are not blocked by bilirubin, suggesting that an acute application of bil- All experiments were performed on internal carotid arteries of the cat, except those for ATP-induced vasodilations, which were performed on basilar arteries of the dog, and those for NE-and ISO-induced vasodilations, which were performed on internal carotid arteries of the pig. n, no. of experiments; ACh, acetylcholine; CCh, carbachol; NE, norepinephrine; ISO, isoproterenol; PPV, papav erine; SNP, sodium nitroprusside.
a Geometric means with 95% confidence intervals. b Significantly different from control value (p < 0.01, paired Student t test).
irubin does not interfere with the synthesis of cyclic GMP in smooth muscle cells. It is well established that endothelial cells play an important role in modulating vascular tone (Furchgott and Zawadzki, 1980; Shirasaki et aI. , 1988) . Many vasodilator agents including ACh, ATP, and A-23187 are known to act through the release of endothelium-derived relaxing factor(s) (Furchgott and Zawadzki, 1980; Gordon and Mar tin, 1983) . In arterial preparations without endothe lial cells, these agents induced vasoconstriction ex clusively (Furchgott and Zawadzki, 1980; Lee, 1980) . Endothelium-derived relaxing factor(s) is thought to activate guanylate cyclase in smooth muscle cells resulting in enhanced cyclic GMP lev els and vasodilation (Rapoport and Murad, 1983; Shirasaki et aI., 1988) . In the present study, ACh-, ATP-, and A-23187-induced dilations of cerebral ar teries with endothelial cells were blocked by biliru bin present in the bath or after it was washed away (the bilirubin postwash effect). This result demon strates that the endothelium-mediated vasodilation is blocked by bilirubin. It is most likely that biliru bin blocks the endothelium-mediated relaxation by acting on endothelium cells. The exact mechanism of action of this blockade, however, remains to be determined.
In summary, results of the present study indicate that bilirubin per se induces a potent cerebral va soconstriction. It also potentiates u2-adrenocep tor-mediated constriction and attenuates the endo thelium-dependent relaxation. These findings sug-gest that bilirubin can enhance vasoconstriction and therefore may play a role in the pathogenesis of cerebral vasospasm in vivo.
It has been suggested that in the early phase of the delayed cerebral vasospasm after SAH, hemo globin plays a major pathophysiological role (Lee et aI. , 1988) . While hemoglobin is converted to biliru bin and the concentration of bilirubin is enhanced, vasoconstriction and blockade of the endothelium mediated vasodilations can be attributed to both he moglobin and bilirubin. Later, when bilirubin is gradually washed out by CSF bulk flow, the biliru bin postwash effect may contribute to potentiated adrenoceptor-mediated constrictions, continual at tenuation of endothelium-dependent relaxations, and an enhanced overall constriction or vasospasm; whether or not this effect of bilirubin occurs in vivo remains to be verified.
